September 23, 2015
At Mylan, we believe every disease should have a treatment and every epidemic should come to an end. That’s why our facilities around the world are committed to advancing the future of healthcare with innovations in generics and specialty medicines.
Our growing portfolio of over 2,700 products spans numerous therapeutic areas, including respiratory and allergy, dermatology, and oncology.
And our growing expertise in the R&D of complex medicines, such as biosimilars, antiretrovirals, and transdermals, helps enable you to meet the needs of your patients.
Innovating for a healthier future — it’s another way we’re creating Better health for a better world®